Glaxo paid 14.6 million USD in 6 months to doctors for “consulting services”
Another one bites the Dust.
Voluntarily.
Hope this heralds a new era in Pharma-marketing strategies.
Glaxo Publishes List Of Fees Paid To Doctors
Yet another drugmaker is uttering the ‘T’ word - transparency. This time around, GlaxoSmithKline has published a list of fees paid between April 1 and June 30 to US healthcare professionals for speaking and consulting services. The drugmaker plans to update the list quarterly, although there was no word on disclosing this info for previous periods (see if you can find anyone you know on the list).
By its own tally, Glaxo paid $14.6 million to approximately 3,700 US docs and other healthcare professionals during those six months for speaking or consulting services. And the average amount spent per healthcare professional in the report was $3,909. Take a look and tell us what else you would like to see disclosed.
In recent months, Merck and Lilly have taken similar steps (see here and here). These moves come amid growing controversy over the influence such payments may have over medical treatment. Read more at www.pharmalot.com
